In the study of prothrombin activity of FGL2 in peripheral blood monocytes of B-cell lymphoma, Rabizad et al. measured the thrombin level of non-Hodgkinundefineds lymphoma (NHL) and normal controls and indicated that the activity of FGL2 prothrombin in NHL is elevated in active lymphoma, which can be used as a prospective marker for remission of lymphoma 39. Here, FGL2 is linked to non-Hodgkin lymphoma.